Acute Radiation Syndrome
3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Humanetics Corp.MN - Roseville
2 programs2
BIO 300 CapsulesPhase 11 trial
BIO 300 Oral PowderPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Humanetics Corp.BIO 300 Oral Powder
iNtRON BiotechnologyKMRC011 5μg or Placebo
Humanetics Corp.BIO 300 Capsules
Clinical Trials (3)
Total enrollment: 84 patients across 3 trials
BIO 300 Oral Powder Safety and Pharmacokinetics
Start: Dec 2020Est. completion: Jul 202134 patients
Phase 1Completed
A Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of KMRC011
Start: Jun 2018Est. completion: Nov 201926 patients
Phase 1Completed
Safety and Pharmacokinetic Study of BIO 300 Capsules
Start: Jun 2007Est. completion: Oct 200724 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.